This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience
September 16-17, 2025
Sheraton BostonBoston, MA

Tracy Du
Corporate Controller at Blueprint Medicines, A Sanofi Company
Speaker

Profile

Tracy is a senior leader with a proven track record of leadership and strategic vision in the life sciences industry. Currently, as Vice President, Corporate Controller at Blueprint Medicines, now a Sanofi company, she oversees a global accounting organization responsible for all aspects of accounting operations, SEC reporting, technical accounting, Sarbanes-Oxley compliance, and revenue operations for product sales and collaboration arrangements. In this capacity, Tracy has spearheaded the successful launch and commercialization of two novel drug products, driving cross-functional collaboration and ensuring seamless integration of accounting with broader business objectives. Prior to joining Blueprint Medicines, Tracy held various accounting leadership roles at Biogen. She began her career at PwC, where she developed a deep expertise in technical accounting.

Agenda Sessions

  • Commercial Readiness: Accounting & Finance Implications as you prepare for launch

    2:15pm